AaviGen GmbH
Pharmaindustrie • Wissenschaft & Forschung • Erziehung, Bildung und Training • 11-50 Mitarbeiter
Fakten
- Branche PharmaindustrieWissenschaft & ForschungErziehung, Bildung und Training
- Gegründet 2019
- Adresse Im Neuenheimer Feld 582, Heidelberg
- Unternehmensgröße 11-50
Über uns
AaviGen is a pre-clinical stage biotechnology company focused on the development of curative gene therapies for genetic and acquired cardiovascular and cardiopulmonary diseases. Its lead program employs heart-specific recombinant Adeno-Associated Viruses (AAV) to bring therapeutic genes with unprecedented safety and precision to the diseased heart via a simple one-time intravenous injection. In executing on its program, AaviGen builds on the expertise and track record of its interdisciplinary leadership team. The company brings together leading knowledge in clinical cardiology & pneumology, virology & genetic vector engineering as well as gene therapy medicinal product development.
){kind=logo}